1.87
+0.06(+3.31%)
Currency In USD
Address
4800 Montgomery Lane
Bethesda, MD 20814
United States of America
Phone
301 500 1556
Sector
Healthcare
Industry
Biotechnology
Employees
23
First IPO Date
March 19, 2021
| Name | Title | Pay | Year Born |
| Mr. Gene Mack M.B.A. | President, Chief Executive Officer & Director | 535,091 | N/A |
| Dr. Khalid Islam Ph.D. | Chairman & Founder | 75,000 | 1955 |
| Mr. Gianluca Fuggetta | Senior Vice President of Finance & Principal Financial Officer | 228,345 | 1989 |
| Dr. Terenzio Ignoni Pharm.D. | Senior Vice President of Technical Operations | 0 | N/A |
| Dr. Joanne Taylor Ph.D. | Senior Vice President of Research | 0 | N/A |
| Dr. Jonas Hannestad M.D., Ph.D. | Chief Medical Officer | 0 | N/A |
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland.